Authors from CSIC and CNIO propose that cognitive loss in patients with brain metastases may be due to the interference created by the cancer in neuronal circuits
Read moreLos investigadores han descubierto un grupo de neuronas, ubicadas en la corteza prefrontal, que se caracteriza por producir la hormona liberadora de corticotropina (CRH) y emitir sus axones a la regiÃ...
Read moreTres recientes investigaciones, apuntan al factor plaquetario 4 (PF4), una proteÃna liberada por las plaquetas al activarse, como elemento de la sangre con efecto antienvejecimiento. Además, tambié...
Read moreAmong the new technologies already being developed and expected to be launched soon is an application that could monitor patients with traumatic brain injury (TBI) at home
Read moreDirect transport to a referral centre for endovascular treatment may not be the best option for patients with a final diagnosis of intracerebral haemorrhage or haemorrhagic stroke, according to the re...
Read moreIt has been identified the structure-function relationship of the N-terminal domains of the AMPA glutamate receptor GluA1, which are major mediators of excitatory neurotransmission throughout the brai...
Read moreLa herramienta desarrollada por un investigador del CSIC permite realizar cálculos sobre circuitos neuronales, la presencia de simetrÃas y corroborar hipótesis experimentales
Read moreMediante el uso de minimodelos del cerebro humano, la bioinformática y la inteligencia artificial, investigadores austriacos y suizos han desarrollado un sistema para identificar los tipos de célula...
Read moreHan impulsado la creación de la Red Temática Nacional en Distrofia Miotónica tipo 1 que reúne a los principales grupos de investigación en DM1 y desarrollo de terapias basadas en oligonucleótido...
Read moreThe findings support the hypothesis that fluctuating hormones, mainly estrogens, are related to changes in the human brain structure, but what is yet to be determined is how this influences neuroplast...
Read moreIt has been developed a new model of Alzheimer's disease to address the role of one of its risk factors: herpes virus. The results, published in the journal Microorganisms , determine the usefulness o...
Read more​3P Biopharmaceuticals and the Swedish company, Toleranzia AB, have successfully accomplished 1000 L full-scale GMP manufacturing of TOL2 drug substance destinated to be used in clinical study.
Read more